Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 80.

Frick, Sven; Müller, Daniel; Kullak-Ublick, Gerd A; Jetter, Alexander (2019). Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases? European Journal of Clinical Pharmacology, 75(3):335-342.

Essers, Dirk; Schäublin, Martina; Kullak-Ublick, Gerd A; Weiler, Stefan (2019). Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase. European Journal of Clinical Pharmacology, 75(3):409-416.

Church, Rachel J; Kullak-Ublick, Gerd A; Aubrecht, Jiri; et al (2019). Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology, 69(2):760-773.

Tcymbarevich, Irina V; Eloranta, Jyrki J; Rossel, Jean-Benoît; Obialo, Nicole; Spalinger, Marianne; Cosin-Roger, Jesus; Lang, Silvia; Kullak-Ublick, Gerd A; Wagner, Carsten A; Scharl, Michael; Seuwen, Klaus; Ruiz, Pedro A; Rogler, Gerhard; de Vallière, Cheryl; Misselwitz, Benjamin; Swiss IBD Cohort Study Group (2019). The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation. BMC Gastroenterology, 19(1):2.

Uteng, Marianne; Urban, Laszlo; Brees, Dominique; Muller, Patrick Y; Kullak-Ublick, Gerd A; Bouchard, Page; Tougas, Gervais; Chibout, Salah-Dine (2019). Safety differentiation: emerging competitive edge in drug development. Drug Discovery Today, 24(1):285-292.

Akhmedov, Alexander; Bonetti, Nicole R; Reiner, Martin F; Spescha, Remo D; Amstalden, Heidi; Merlini, Mario; Gaul, Daniel S; Diaz-Cañestro, Candela; Spescha, Rebecca S; Semerano, Aurora; Giacalone, Giacomo; Savarese, Gianluigi; Montecucco, Fabrizio; Kulic, Luka; Nitsch, Roger M; Matter, Christian M; Kullak-Ublick, Gerd A; Sessa, Maria; Lüscher, Thomas F; Beer, Jürg H; Liberale, Luca; Camici, Giovanni G (2018). Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury. Journal of Cerebral Blood Flow and Metabolism:Epub ahead of print.

Diaz-Cañestro, Candela; Merlini, Mario; Bonetti, Nicole R; Liberale, Luca; Wüst, Patricia; Briand-Schumacher, Sylvie; Klohs, Jan; Costantino, Sara; Miranda, Melroy; Schoedon-Geiser, Gabriele; Kullak-Ublick, Gerd A; Akhmedov, Alexander; Paneni, Francesco; Beer, Jürg H; Lüscher, Thomas F; Camici, Giovanni G (2018). Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury. International Journal of Cardiology, 260:148-155.

Jödicke, Annika M; Curkovic, Ivanka; Zellweger, Urs; Tomka, Ivan T; Neuer, Thomas; Kullak-Ublick, Gerd A; Roos, Malgorzata; Egbring, Marco (2018). Analysis of drug-drug interactions in Swiss claims data using tizanidine and ciprofloxacin as a prototypical contraindicated combination. The Annals of Pharmacotherapy, 52(10):983-991.

Schadt, Heiko S; Wolf, Armin; Mahl, Joerg Andreas; Wuersch, Kuno; Couttet, Philippe; Schwald, Marianne; Fischer, Audrey; Lienard, Mathilde; Emotte, Corinne; Teng, Chi-Hse; Skuba, Elizabeth; Richardson, Terrilyn A; Manenti, Luigi; Weiss, Andreas; Graus Porta, Diana; Fairhurst, Robin A; Kullak-Ublick, Gerd A; Chibout, Salah-Dine; Pognan, Francois; Kluwe, William; Kinyamu-Akunda, Jacqueline (2018). Bile acid sequestration by cholestyramine mitigates FGFR4 inhibition-induced ALT elevation. Toxicological Sciences, 163(1):265-278.

Diaz-Cañestro, Candela; Merlini, Mario; Bonetti, Nicole R; Liberale, Luca; Wüst, Patricia; Briand-Schumacher, Sylvie; Klohs, Jan; Costantino, Sara; Miranda, Melroy; Schoedon-Geiser, Gabriele; Kullak-Ublick, Gerd A; Akhmedov, Alexander; Paneni, Francesco; Beer, Jürg H; Lüscher, Thomas F; Camici, Giovanni G (2018). Corrigendum to ‘Sirtuin 5 as a novel target to blunt blood–brain barrier damage induced by cerebral ischemia/reperfusion injury’ [Int. J. Cardiol. 260 (2018) 148–155]. International Journal of Cardiology, 271:405.

Visentin, Michele; Lenggenhager, Daniela; Gai, Zhibo; Kullak-Ublick, Gerd A (2018). Drug-induced bile duct injury. Biochimica et biophysica acta, 1864(4):1498-1506.

Visentin, Michele; Torozi, Angelo; Gai, Zhibo; Hausler, Stephanie; Li, Chao; Hiller, Christian; Schraml, Peter H; Moch, Holger; Kullak-Ublick, Gerd A (2018). Fluorocholine transport mediated by the organic cation transporter 2 (OCT2,SLC22A2): implication for imaging of kidney tumors. Drug Metabolism and Disposition, 46(8):1129-1136.

Gai, Zhibo; Visentin, Michele; Gui, Ting; Zhao, Lin; Thasler, Wolfgang E; Hausler, Stephanie; Hartling, Ivan; Cremonesi, Alessio; Hiller, Christian; Kullak-Ublick, Gerd A (2018). The effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling and hepatic inflammation. Molecular Pharmacology, 94(2):802-811.

Visentin, Michele; Gai, Zhibo; Torozi, Angelo; Hiller, Christian; Kullak-Ublick, Gerd A (2017). Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5). Drug Metabolism and Disposition, 45(12):1240-1244.

Boström, Adrian E; Ciuculete, Diana-Maria; Attwood, Misty; Krattinger, Regina; Nikontovic, Lamia; Titova, Olga E; Kullak-Ublick, Gerd A; Mwinyi, Jessica; Schiöth, Helgi B (2017). A MIR4646 associated methylation locus is hypomethylated in adolescent depression. Journal of Affective Disorders, 220:117-128.

Nicoletti, Paola; Aithal, Guruprasad P; Bjornsson, Einar S; Andrade, Raul J; Sawle, Ashley; Arrese, Marco; Barnhart, Huiman X; Bondon-Guitton, Emmanuelle; Hayashi, Paul H; Bessone, Fernando; Carvajal, Alfonso; Cascorbi, Ingolf; Cirulli, Elizabeth T; Chalasani, Naga; Conforti, Anita; Coulthard, Sally A; Daly, Mark J; Day, Christopher P; Dillon, John F; Fontana, Robert J; Grove, Jane I; Hallberg, Pär; Hernández, Nelia; Ibáñez, Luisa; Kullak-Ublick, Gerd A; Laitinen, Tarja; Larrey, Dominique; Lucena, M Isabel; Maitland-van der Zee, Anke H; Martin, Jennifer H; et al (2017). Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study. Gastroenterology, 152(5):1078-1089.

Kullak-Ublick, Gerd A; Andrade, Raul J; Merz, Michael; End, Peter; Benesic, Andreas; Gerbes, Alexander L; Aithal, Guruprasad P (2017). Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut, 66(6):1154-1164.

Gai, Zhibo; Chu, Lei; Xu, Zhenqiang; Song, Xiaoming; Sun, Dongfeng; Kullak-Ublick, Gerd A (2017). Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage. Scientific Reports, 7(1):1-16.

Wang, Huaiguo; Li, Jian; Gai, Zhibo; Kullak-Ublick, Gerd A; Liu, Zewei (2017). TNF-α deficiency prevents renal inflammation and oxidative stress in obese mice. Kidney & Blood Pressure Research, 42(3):416-427.

de Vallière, Cheryl; Cosin-Roger, Jesus; Simmen, Simona; Atrott, Kirstin; Melhem, Hassan; Zeitz, Jonas; Madanchi, Mehdi; Tcymbarevich, Irina; Fried, Michael; Kullak-Ublick, Gerd A; Vavricka, Stephan R; Misselwitz, Benjamin; Seuwen, Klaus; Wagner, Carsten A; Eloranta, Jyrki J; Rogler, Gerhard; Ruiz, Pedro A (2016). Hypoxia positively regulates the expression of pH-sensing G-protein-coupled receptor OGR1 (GPR68). Cellular and Molecular Gastroenterology and Hepatology, 2(6):796-810.

Egbring, Marco; Far, Elmira; Roos, Malgorzata; Dietrich, Michael; Brauchbar, Mathis; Kullak-Ublick, Gerd A; Trojan, Andreas (2016). A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. Journal of Medical Internet Research, 18(9):e238.

Schadt, Heiko S; Wolf, Armin; Pognan, Francois; Chibout, Salah-Dine; Merz, Michael; Kullak-Ublick, Gerd A (2016). Bile acids in drug induced liver injury: Key players and surrogate markers. Clinics and Research in Hepatology and Gastroenterology, 40(3):257-266.

Krattinger, Regina; Boström, Adrian; Lee, Serene M L; Thasler, Wolfgang E; Schiöth, Helgi B; Kullak-Ublick, Gerd A; Mwinyi, Jessica (2016). Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes. Life Sciences, 156:47-56.

Sigaroudi, Ali; Kullak-Ublick, Gerd A; Weiler, Stefan (2016). Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine. European Journal of Clinical Pharmacology, 72(3):377-378.

Stocker, Albina; Hilbers, Marie-Luise; Gauthier, Claire; Grogg, Josias; Kullak-Ublick, Gerd A; Seifert, Burkhardt; Varga, Zsuzsanna; Trojan, Andreas (2016). HER2/CEP17 ratios and clinical outcome in HER2-positive early breast cancer undergoing trastuzumab-containing therapy. PLoS ONE, 11(7):e0159176.

Kullak-Ublick, Gerd A; Gubler, Christoph; Spanaus, Katharina; Ismair, Manfred G; Claro da Silva, Tatiana; Jetter, Alexander (2016). No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers. European Journal of Clinical Pharmacology, 72(7):797-805.

Gai, Zhibo; Visentin, Michele; Hiller, Christian; Krajnc, Evelin; Li, Tongzhou; Zhen, Junhui; Kullak-Ublick, Gerd A (2016). Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrobial Agents and Chemotherapy, 60(9):5573-5580.

Weiler, Stefan; Kullak-Ublick, Gerd A (2016). Risiken bei der Behandlung mit neuen Kinase-Inhibitoren in der Onkologie: Welche Targets haben die «Targeted» Therapien? In: SVV. Medinfo: Mitteilungen zu Themen der Privatversicherten. Zürich: ASA | SVV, 25-40.

Claro da Silva, Tatiana; Hiller, Christian; Gai, Zhibo; Kullak-Ublick, Gerd A (2016). Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. Journal of Steroid Biochemistry and Molecular Biology, 163:77-87.

Krattinger, Regina; Boström, Adrian; Schiöth, Helgi B; Thasler, Wolfgang E; Mwinyi, Jessica; Kullak-Ublick, Gerd A (2016). microRNA-192 suppresses the expression of the farnesoid X receptor. American Journal Of Physiology. Gastrointestinal And Liver Physiology, 310(11):G1044-G1051.

Gai, Zhibo; Gui, Ting; Hiller, Christian; Kullak-Ublick, Gerd A (2015). Farnesoid X receptor protects against kidney injury in uninephrectomized obese mice. Journal of Biological Chemistry:2397-2411.

Weiler, Stefan; Bellmann, Romuald; Kullak-Ublick, Gerd A (2015). 5-Oxoprolin (Pyroglutaminsäure) Azidose unter Paracetamol - Eine Differentialdiagnose der metabolischen Azidose mit erhöhter Anionenlücke. Therapeutische Umschau. Revue thérapeutique, 72(11-12):737-741.

Visentin, Michele; Stieger, Bruno; Merz, Michael; Kullak-Ublick, Gerd A (2015). Octreotide Inhibits the Bilirubin Carriers Organic Anion Transporting Polypeptides 1B1 and 1B3 and the Multidrug Resistance-Associated Protein 2. Journal of Pharmacology and Experimental Therapeutics, 355(2):145-151.

de Vallière, Cheryl; Vidal, Solange; Clay, Ieuan; Jurisic, Giorgia; Tcymbarevich, Irina; Lang, Silvia; Ludwig, Marie-Gabrielle; Okoniewski, Michal; Eloranta, Jyrki J; Kullak-Ublick, Gerd A; Wagner, Carsten A; Rogler, Gerhard; Seuwen, Klaus (2015). The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment. American Journal Of Physiology. Gastrointestinal And Liver Physiology, 309(6):475-490.

de Vallière, Cheryl; Wang, Yu; Eloranta, Jyrki J; Vidal, Solange; Clay, Ieuan; Spalinger, Marianne R; Tcymbarevich, Irina; Terhalle, Anne; Ludwig, Marie-Gabrielle; Suply, Thomas; Fried, Michael; Kullak-Ublick, Gerd A; Frey-Wagner, Isabelle; Scharl, Michael; Seuwen, Klaus; Wagner, Carsten A; Rogler, Gerhard (2015). G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation. Inflammatory Bowel Diseases, 21(6):1269-1281.

Gerster, Ragam; Eloranta, Jyrki J; Hausmann, Martin; Ruiz, Pedro A; Cosin-Roger, Jesus; Terhalle, Anne; Ziegler, Urs; Kullak-Ublick, Gerd A; von Eckardstein, Arnold; Rogler, Gerhard (2015). Anti-inflammatory function of high-density lipoproteins via autophagy of IκB Kinase. Cellular and Molecular Gastroenterology and Hepatology, 1(2):171-187.e1.

Weiler, Stefan; Merz, Michael; Kullak-Ublick, Gerd A (2015). Drug-induced liver injury: the dawn of biomarkers? F1000 Prime Reports, 7(34):online.

Chin, Siew Hung; Item, Flurin; Wueest, Stephan; Zhou, Zhou; Wiedemann, Michael S F; Gai, Zhibo; Schoenle, Eugen J; Kullak-Ublick, Gerd A; Al-Hasani, Hadi; Konrad, Daniel (2015). Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitivity in obese mice. Diabetes, 64(4):1131-1141.

Schaffner, Carlos A; Mwinyi, Jessica; Gai, Zhibo; Thasler, Wolfgang E; Eloranta, Jyrki J; Kullak-Ublick, Gerd A (2015). The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes. Liver International, 35(4):1152-1161.

Reiber, Claudine; Senn, Oliver; Müller, Daniel; Kullak-Ublick, Gerd A; Corti, Natascia (2015). Therapeutic drug monitoring of daptomycin: a retrospective monocentric analysis. Therapeutic drug monitoring, 37(5):634-640.

Kullak-Ublick, Gerd A; Merz, Michael; Griffel, Louis; Kaplowitz, Neil; Watkins, Paul B (2014). Liver safety assessment in special populations (hepatitis B, C, and oncology trials). Drug Safety, 37 Suppl:57-62.

Merz, Michael; Lee, Kwan R; Kullak-Ublick, Gerd A; Brueckner, Andreas; Watkins, Paul B (2014). Methodology to assess clinical liver safety data. Drug Safety, 37 Suppl:33-45.

Gai, Zhibo; Hiller, Christian; Chin, Siew Hung; Hofstetter, Lia; Stieger, Bruno; Konrad, Daniel; Kullak-Ublick, Gerd A (2014). Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney. Biochimica et Biophysica Acta, 1842(9):1870-1878.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Mwinyi, Jessica; Vokinger, Kerstin; Jetter, Alexander; Breitenstein, Urs; Hiller, Christian; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy. Cancer Chemotherapy and Pharmacology, 73(6):1181-1188.

Stieger, Bruno; Kullak-Ublick, Gerd A (2014). Arzneimittel-Interaktionen auf der Ebene von Transportern des Hepatozyten. Pharmazeutische Medizin, 16(1):36-41.

Meli, Marianne; Rauber-Lüthy, Christine; Hoffmann-Walbeck, Petra; Reinecke, Hans-Jürgen; Prasa, Dagmar; Stedtler, Uwe; Färber, Elke; Genser, Dieter; Kupferschmidt, Hugo; Kullak-Ublick, Gerd A; Ceschi, Alessandro (2014). Atypical antipsychotic poisoning in young children: a multicentre analysis of poisons centres data. European Journal of Pediatrics, 173(6):743-750.

Gai, Zhibo; Chu, Lei; Hiller, Christian; Arsenijevic, Denis; Penno, Carlos A; Montani, Jean-Pierre; Odermatt, Alex; Kullak-Ublick, Gerd A (2014). Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 306(1):F130-F137.

Franzen, Daniel; Kohler, Malcolm; Degrandi, Colette; Kullak-Ublick, Gerd A; Ceschi, Alessandro (2014). Fire eater's lung: Retrospective analysis of 123 cases reported to a national poison center. Respiration, 87(2):98-104.

Russmann, Stefan; Niedrig, David F; Budmiger, Mathias; Schmidt, Caroline; Stieger, Bruno; Hürlimann, Sandra; Kullak-Ublick, Gerd A (2014). Rivaroxaban postmarketing risk of liver injury. Journal of Hepatology, 61(2):293-300.

Biedermann, Luc; Mwinyi, Jessica; Scharl, Michael; Frei, Pascal; Zeitz, Jonas; Kullak-Ublick, Gerd A; Vavricka, Stephan R; Fried, Michael; Weber, Achim; Humpf, Hans-Ulrich; Peschke, Simone; Jetter, Alexander; Krammer, Gerhard; Rogler, Gerhard (2013). Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - An open pilot study. Journal of Crohn's & colitis, 7(4):271-279.

Stieger, Bruno; Kullak-Ublick, Gerd A (2013). Bile salt Export Pump BSEP (ABCB11): Role in liver physiology and liver disease. In: Ishikawa, T; Kim, R B; König, J. Pharmacogenomics of Human Drug Transporters: Clinical Impacts. Hoboken, NJ, USA: Wiley-Blackwell, 295-309.

Zorina, Olesya I; Haueis, Patrick; Greil, Waldemar; Grohmann, Renate; Kullak-Ublick, Gerd A; Russmann, Stefan (2013). Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients. Drug Safety, 36(4):247-258.

Rauber-Lüthy, Christine; Hofer, Katharina E; Bodmer, Michael; Kullak-Ublick, Gerd A; Kupferschmidt, Hugo; Ceschi, Alessandro (2013). Gastric pharmacobezoars in quetiapine extended-release overdose: a case series. Clinical Toxicology, 51(10):937-940.

González-Carmona, Maria A; Quasdorff, Maria; Vogt, Annabelle; Tamke, Anja; Yildiz, Yildiz; Hoffmann, Per; Lehmann, Thomas; Bartenschlager, Ralf; Engels, Joachim W; Kullak-Ublick, Gerd A; Sauerbruch, Tilman; Caselmann, Wolfgang H (2013). Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN). Antiviral Research, 97(1):49-59.

Heinrich, Henriette; Kullak-Ublick, Gerd A; Krayenbühl, Pierre-Alexandre (2013). Leberlebendspende – primum nihil nocere? Praxis, 102(21):1277-1283; quiz 1284.

Curkovic, Ivanka; Rentsch, Katharina M; Frei, Pascal; Fried, Michael; Rogler, Gerhard; Kullak-Ublick, Gerd A; Jetter, Alexander (2013). Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations. European Journal of Clinical Pharmacology, 69(8):1521-1531.

Bloch-Teitelbaum, Alexandra; Lüde, Saskia; Rauber-Lüthy, Christine; Kupferschmidt, Hugo; Russmann, Stefan; Kullak-Ublick, Gerd A; Ceschi, Alessandro (2013). Medication wrong route administration: a poisons center-based study. Expert Opinion on Drug Safety, 12(2):145-152.

Gutscher, Karen; Rauber-Lüthy, Christine; Haller, Marina; Braun, Michèle; Kupferschmidt, Hugo; Kullak-Ublick, Gerd A; Ceschi, Alessandro (2013). Patterns of toxicity and factors influencing severity in acute adult trimipramine poisoning. British Journal of Clinical Pharmacology, 75(1):227-235.

Kullak-Ublick, Gerd A (2013). Personalisierte Medizin: Fokus der Klinischen Pharmakologie. Pipette, 1:8-9.

Godoy, Patricio; Hewitt, Nicola J; et al; Kelm, Jens M; Kullak-Ublick, Gerd A; Messner, Simon; Mwinyi, Jessica (2013). Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of toxicology, 87(8):1315-1530.

Curkovic, Ivanka; Egbring, Marco; Kullak-Ublick, Gerd A (2013). Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Digestive Diseases, 31(3-4):368-373.

Stieger, Bruno; Kullak-Ublick, Gerd A (2013). Role of membrane transport in hepatotoxicity and pathogenesis of drug-induced cholestasis. In: Kaplowitz, N; DeLeve, L D. Drug-Induced Liver Disease. unknown: Elsevier, 123-133.

Curkovic, Ivanka; Egbring, Marco; Kullak-Ublick, Gerd A (2013). Thrombozytenaggregationshemmer: Was sind die Risiken? Praxis, 102(20):1243-1250.

Attinkara, Ragam; Mwinyi, Jessica; Truninger, Kaspar; Regula, Jaroslaw; Gaj, Pawel; Rogler, Gerhard; Kullak-Ublick, Gerd A; Eloranta, Jyrki J (2012). Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease. BMC Research Notes, 5:461.

Fritz, Daniela; Ceschi, Alessandro; Curkovic, Ivanka; Huber, Martin; Egbring, Marco; Kullak-Ublick, Gerd A; Russmann, Stefan (2012). Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients. European Journal of Clinical Pharmacology, 68(8):1209-1219.

Wojtal, Kacper A; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Weber, Achim; Eloranta, Jyrki J; Kullak-Ublick, Gerd A; Vavricka, Stephan R (2012). Fc gamma receptor CD64 modulates the inhibitory activity of infliximab. PLoS ONE, 7(8):e43361.

Trdan Lušin, Tina; Mrhar, Aleš; Stieger, Bruno; Kullak-Ublick, Gerd A; Marc, Janja; Ostanek, Barbara; Zavratnik, Andrej; Kristl, Albin; Berginc, Katja; Delić, Katja; Trontelj, Jurij (2012). Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Translational Research, 160(4):298-308.

Schenk-Jaeger, Katharina M; Rauber-Lüthy, Christine; Bodmer, Michael; Kupferschmidt, Hugo; Kullak-Ublick, Gerd A; Ceschi, Alessandro (2012). Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity. European Journal of Internal Medicine, 23(4):e85-91.

Goltz, Lisa; Kullak-Ublick, Gerd A; Kirch, Wilhelm (2012). Potentially inappropriate prescribing for elderly outpatients in Germany: a retrospective claims data analysis. International journal of clinical pharmacology and therapeutics, 50(3):185-94.

Taegtmeyer, Anne B; Leuppi, Jörg D; Kullak-Ublick, Gerd A (2012). Roflumilast--a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. Swiss Medical Weekly, 142:w13628.

Eloranta, Jyrki J; Hiller, Christian; Juttner, Moritz; Kullak-Ublick, Gerd A (2012). The SLCO1A2 Gene, Encoding the Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2), is Transactivated by the Vitamin D Receptor (VDR). Molecular Pharmacology, 82(1):37-46.

Mwinyi, Jessica; Grete-Wenger, Christa; Eloranta, Jyrki J; Kullak-Ublick, Gerd A (2012). The impact of PPARγ genetic variants on IBD susceptibility and IBD disease course. PPAR Research, 2012:349469.

Far, Elmira; Curkovic, Ivanka; Byrne, Kelly; Roos, Malgorzata; Egloff, Isabelle; Dietrich, Michael; Kirch, Wilhelm; Kullak-Ublick, Gerd A; Egbring, Marco (2012). Validation of a transparent decision model to rate drug interactions. BMC Pharmacology & Toxicology, 13:7.

Taegtmeyer, Anne B; Breen, Jane B; Smith, John; Rogers, Paula; Kullak-Ublick, Gerd A; Yacoub, Magdi H; Banner, Nicholas R; Barton, Paul J R (2011). Effect of ABCB1 genotype on pre- and post-cardiac transplantation plasma lipid concentrations. Journal of Cardiovascular Translational Research, 4(3):304-312.

Egbring, Marco; Far, Elmira; Knuth, Alexander; Roos, Malgorzata; Kirch, Wilhelm; Kullak-Ublick, Gerd A (2011). Performance of different data sources in identifying adverse drug events in hospitalized patients. European Journal of Clinical Pharmacology, 67(9):909-918.

Noe, Johannes; Kullak-Ublick, Gerd A; Jochum, Wolfram; Stieger, Bruno; Kerb, Reinhold; Haberl, Michael; Müllhaupt, Beat; Meier, Peter J; Pauli-Magnus, Christiane (2005). Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. Journal of Hepatology, 43(3):536-543.

Fattinger, Karin; Kullak-Ublick, Gerd A (2002). Letter to the editor by Drs. Gatti and Bertazzoli entitled “Evaluation of isolated case reports on hepatotoxicity”. European Journal of Clinical Pharmacology, 57(12):921-922.

Fattinger, Karin; Roos, Malgorzata; Vergères, Patrice; Holenstein, Clemens; Kind, Brigitt; Masche, Urspeter; Stocker, David N; Braunschweig, Suzanne; Kullak-Ublick, Gerd A; Galeazzi, Renato L; Follath, Ferenc; Gasser, Theo; Meier, Peter J (2000). Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. British Journal of Clinical Pharmacology, 49(2):158-167.

Kullak-Ublick, Gerd A; Ismair, Manfred G; Kubitz, Ralf; Schmitt, Marcus; Häussinger, Dieter; Stieger, Bruno; Hagenbuch, Bruno; Meier, Peter J; Beuers, Ulrich; Paumgartner, Gustav (2000). Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology, 34(1/2):1-9.

This list was generated on Sat Jun 15 14:31:21 2019 CEST.